The Impact of Insulin Staging in the Context of Pharmaceutical Care on Patients with Type 2 Diabetes Mellitus

Kawa Ahmad Obeid, Ahmed Ghafour Hamasaeed Department of Clinical Pharmacy/ College of Pharmacy, University of Sulaimani, Sulaimani, Kurdistan Region, IraqCorrespondence: Kawa Ahmad Obeid, College of Pharmacy, University of Sulaimani, Old Campus, Sulaimaniyah, Kurdistan Region, 46001, Iraq, Tel +9647...

Full description

Bibliographic Details
Main Authors: Obeid KA, Hamasaeed AG
Format: Article
Language:English
Published: Dove Medical Press 2023-01-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/the-impact-of-insulin-staging-in-the-context-of-pharmaceutical-care-on-peer-reviewed-fulltext-article-DMSO
_version_ 1797954405149966336
author Obeid KA
Hamasaeed AG
author_facet Obeid KA
Hamasaeed AG
author_sort Obeid KA
collection DOAJ
description Kawa Ahmad Obeid, Ahmed Ghafour Hamasaeed Department of Clinical Pharmacy/ College of Pharmacy, University of Sulaimani, Sulaimani, Kurdistan Region, IraqCorrespondence: Kawa Ahmad Obeid, College of Pharmacy, University of Sulaimani, Old Campus, Sulaimaniyah, Kurdistan Region, 46001, Iraq, Tel +9647501112412, College of Pharmacy, University of Sulaimani, Email kawa.uobaed@univsul.edu.iqPurpose: The problem of polypharmacy and the nature of the disease make patients with type 2 diabetes mellitus highly vulnerable to drug therapy problems, especially those who are on insulin therapy. Despite this challenge, reaching the desired clinical outcome and using an appropriate insulin regimen are also considered a controversial issue among clinicians. The current study is designed to explore the impact of insulin staging regimens in the context of pharmaceutical care on patients with type 2 diabetes mellitus.Patients and Methods: This study is a randomized interventional comparative study of a few groups. It was conducted at the Diabetes and Endocrine Centre in Sulaymaniyah City in Iraq from January to August 2022. Patients with T2DM who were on insulin therapy were enrolled in this trial. The participants were divided into two groups, the interventional and non-interventional groups. The insulin regimen was modified, and pharmaceutical care process was performed for the intervention group. Drug therapy problems (DTPs) and clinical parameters were monitored both groups over the course of six months.Results: A total of 67 patients with T2DM on insulin were included in this study, and of them, 73% were females, with a mean age of 57.34 ± 7.825 years. The groups were randomly divided into intervention and non-intervention groups. After six months of applying insulin staging in the context of pharmaceutical care, FPG (Mean Diff.= 72.25, 95% CI of diff.= 20.44 to 124.1), HbA1c (Mean Diff.= 2.087, 95% CI of diff.= 1.151 to 3.023) and DTP were significantly improved in the intervention group.Conclusion: Implementing the insulin staging approach within the context of the pharmaceutical care process showed a significant impact on controlling plasma glucose levels.Keywords: drug therapy problem, clinical pharmacy, insulin staging, adherence, insulin regimen
first_indexed 2024-04-10T23:18:07Z
format Article
id doaj.art-d8020f897f8f4496a368419b05cef7ab
institution Directory Open Access Journal
issn 1178-7007
language English
last_indexed 2024-04-10T23:18:07Z
publishDate 2023-01-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj.art-d8020f897f8f4496a368419b05cef7ab2023-01-12T18:03:06ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072023-01-01Volume 16718380924The Impact of Insulin Staging in the Context of Pharmaceutical Care on Patients with Type 2 Diabetes MellitusObeid KAHamasaeed AGKawa Ahmad Obeid, Ahmed Ghafour Hamasaeed Department of Clinical Pharmacy/ College of Pharmacy, University of Sulaimani, Sulaimani, Kurdistan Region, IraqCorrespondence: Kawa Ahmad Obeid, College of Pharmacy, University of Sulaimani, Old Campus, Sulaimaniyah, Kurdistan Region, 46001, Iraq, Tel +9647501112412, College of Pharmacy, University of Sulaimani, Email kawa.uobaed@univsul.edu.iqPurpose: The problem of polypharmacy and the nature of the disease make patients with type 2 diabetes mellitus highly vulnerable to drug therapy problems, especially those who are on insulin therapy. Despite this challenge, reaching the desired clinical outcome and using an appropriate insulin regimen are also considered a controversial issue among clinicians. The current study is designed to explore the impact of insulin staging regimens in the context of pharmaceutical care on patients with type 2 diabetes mellitus.Patients and Methods: This study is a randomized interventional comparative study of a few groups. It was conducted at the Diabetes and Endocrine Centre in Sulaymaniyah City in Iraq from January to August 2022. Patients with T2DM who were on insulin therapy were enrolled in this trial. The participants were divided into two groups, the interventional and non-interventional groups. The insulin regimen was modified, and pharmaceutical care process was performed for the intervention group. Drug therapy problems (DTPs) and clinical parameters were monitored both groups over the course of six months.Results: A total of 67 patients with T2DM on insulin were included in this study, and of them, 73% were females, with a mean age of 57.34 ± 7.825 years. The groups were randomly divided into intervention and non-intervention groups. After six months of applying insulin staging in the context of pharmaceutical care, FPG (Mean Diff.= 72.25, 95% CI of diff.= 20.44 to 124.1), HbA1c (Mean Diff.= 2.087, 95% CI of diff.= 1.151 to 3.023) and DTP were significantly improved in the intervention group.Conclusion: Implementing the insulin staging approach within the context of the pharmaceutical care process showed a significant impact on controlling plasma glucose levels.Keywords: drug therapy problem, clinical pharmacy, insulin staging, adherence, insulin regimenhttps://www.dovepress.com/the-impact-of-insulin-staging-in-the-context-of-pharmaceutical-care-on-peer-reviewed-fulltext-article-DMSOdrug therapy problemclinical pharmacyinsulin stagingadherenceinsulin regimen.
spellingShingle Obeid KA
Hamasaeed AG
The Impact of Insulin Staging in the Context of Pharmaceutical Care on Patients with Type 2 Diabetes Mellitus
Diabetes, Metabolic Syndrome and Obesity
drug therapy problem
clinical pharmacy
insulin staging
adherence
insulin regimen.
title The Impact of Insulin Staging in the Context of Pharmaceutical Care on Patients with Type 2 Diabetes Mellitus
title_full The Impact of Insulin Staging in the Context of Pharmaceutical Care on Patients with Type 2 Diabetes Mellitus
title_fullStr The Impact of Insulin Staging in the Context of Pharmaceutical Care on Patients with Type 2 Diabetes Mellitus
title_full_unstemmed The Impact of Insulin Staging in the Context of Pharmaceutical Care on Patients with Type 2 Diabetes Mellitus
title_short The Impact of Insulin Staging in the Context of Pharmaceutical Care on Patients with Type 2 Diabetes Mellitus
title_sort impact of insulin staging in the context of pharmaceutical care on patients with type 2 diabetes mellitus
topic drug therapy problem
clinical pharmacy
insulin staging
adherence
insulin regimen.
url https://www.dovepress.com/the-impact-of-insulin-staging-in-the-context-of-pharmaceutical-care-on-peer-reviewed-fulltext-article-DMSO
work_keys_str_mv AT obeidka theimpactofinsulinstaginginthecontextofpharmaceuticalcareonpatientswithtype2diabetesmellitus
AT hamasaeedag theimpactofinsulinstaginginthecontextofpharmaceuticalcareonpatientswithtype2diabetesmellitus
AT obeidka impactofinsulinstaginginthecontextofpharmaceuticalcareonpatientswithtype2diabetesmellitus
AT hamasaeedag impactofinsulinstaginginthecontextofpharmaceuticalcareonpatientswithtype2diabetesmellitus